Company Overview and News
CALGARY, AB / ACCESSWIRE / October 16, 2018 / CANEX Metals Inc. (TSX.V CANX) ("CANEX" or the "Company") has closed a non-brokered private placement for 2,300,000 units ("Common Units") at a price of $0.05 per Common Unit for gross proceeds of $115,000. Each Common Unit consisted of one common share and one common share purchase warrant. Each common share purchase warrant entitles the holder to purchase one common share at a price of $0.
2018-10-01 seekingalpha - 8
Science and art, or if you prefer skill and luck, are both needed for consistent success in short-term trading to long-term investing. Some deny this and say it's all math, claiming that markets always represent fair value. If so, high-frequency trading algo-bot scalpers will always win, meaning people can never outsmart to beat the market as all opportunities and risks are fully discounted into prices.
STZ.B TWX MEAOF BTR AMZN AABA LVNSF FQM NDM MISVF HVBTF GDX AXXDF STZ TWC PRU SLV BABA ATUSF AAUKF VZ BALMF BB FB DB KGI.DB NFLX GOOG GLD TLRY ALS WEED NAK PMNXF AAPL FQVLF PRU ADV BLKCF DIS KL GDXJ EGO FM KGI MSV KGI.DB.A AAL CGC NDMWF ELD BAR NGLOY
MONTRÉAL, 16 août 2018 (GLOBE NEWSWIRE) -- Exploration Midland inc. (“Midland“) (TSX-V : MD) et Altius Minerals Corporation (“Altius”) (TSX:ALS) ont le plaisir d’annoncer la reprise des travaux d’exploration d’été 2018 sur leurs projets d’exploration de métaux de base détenus conjointement (50 %-50 %) à la Baie-James, sur les projets Shire (zinc) et Moria (nickel-cuivre-cobalt. La campagne d’exploration comprendra le décapage mécanique des indices à hautes teneurs et des anomalies géophysiques identifiés en 2017, l’échantillonnage de sols ainsi que de la prospection et cartographie géologique.
ATUSF IAG ALS
MONTREAL, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Midland Exploration inc. (“Midland“) (TSX-V : MD) and Altius Minerals Corporation (“Altius”) (TSX:ALS) are pleased to announce that summer 2018 exploration work will resume on their James Bay base metals exploration projects, namely Shire (zinc), and Moria (nickel-copper-cobalt. Exploration will consist of mechanical trenching of high-grade showings and geophysical anomalies identified in 2017, soil sampling, as well as prospecting and geological mapping.
MD ATUSF ABMBF AEM ABI MDNND IAG ALS
MONTRÉAL, 14 août 2018 (GLOBE NEWSWIRE) -- Exploration Midland inc. (“Midland“) (TSX-V : MD) et Altius Minerals Corporation (“Altius”) (TSX:ALS) ont le plaisir d’annoncer la découverte de nouveaux indices de Cu-Mo-Au-Ag et d’or à la Baie-James. Ces indices ont été trouvés durant un programme régional de génération de projets qui s’est déroulé en juin.
ATUSF IAG ALS
MONTREAL, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Midland Exploration inc. (“Midland“) (TSX-V : MD) and Altius Minerals Corporation (“Altius”) (TSX:ALS) are pleased to announce the discovery of new Cu-Mo-Au-Ag and Au showings in James Bay, Quebec. These showings were found during a regional project generation program performed in June.
MD ATUSF ABMBF AEM ABI MDNND IAG ALS
TORONTO, July 31, 2018 (GLOBE NEWSWIRE) -- CANSTAR RESOURCES INC. (TSXV:ROX) (“Canstar” or the “Company”) is pleased to announce that together with Adventus Zinc Corporation (TSXV:ADZN) (“Adventus”) and Altius Minerals Corporation (TSX:ALS) (“Altius”), it has completed the acquisitions previously announced on February 21, 2018, April 18, 2018, May 31, 2018 and July 18, 2018, pursuant to which Canstar acquired the Newfoundland base-metal exploration assets of Adventus and the Daniel's Harbour zinc project from Altius (the “Transaction”).
WPM ATUSF ROX CSRNF ALS
MONTRÉAL, 31 mai 2018 (GLOBE NEWSWIRE) -- Exploration Midland inc. (“Midland“) (TSX-V:MD) et Altius Minerals Corporation (“Altius”) (TSX:ALS) ont le plaisir d’annoncer la reprise des travaux d’exploration d’été 2018 sur leurs projets d’exploration détenus conjointement (50 %-50 %) à la Baie-James, sur les projets Shire (zinc), Moria (nickel-cuivre-cobalt), Isengard (or) et Gondor (or). La campagne d’exploration comprendra le décapage mécanique des indices à hautes teneurs et des anomalies géophysiques identifiés en 2017 sur Shire et Moria, l’échantillonnage de sols, et de la prospection et cartographie géologique sur les quatre projets.
ATUSF IAG ALS
VANCOUVER, British Columbia, May 30, 2018 (GLOBE NEWSWIRE) -- Constantine Metal Resources Ltd. (TSX Venture:CEM) (OTCQB:CNSND) ("Constantine" or the "Company") is pleased to announce that it has closed the first tranche of its previously announced $10,000,000 private placement. The first tranche consisted of 12,342,013 units (the “Units”) at a price of $0.68 per Unit for aggregate gross proceeds of $8,392,569.
CNSNF ATUSF ALS
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to TSX:ALS / Altius Minerals Corporat on message board site Silicon Investor.